Electrical storm treatment by percutaneous stellate ganglion block: the STAR study
- PMID: 38289867
- PMCID: PMC10919918
- DOI: 10.1093/eurheartj/ehae021
Electrical storm treatment by percutaneous stellate ganglion block: the STAR study
Erratum in
-
Correction to: Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.Eur Heart J. 2024 Oct 14;45(39):4235. doi: 10.1093/eurheartj/ehae631. Eur Heart J. 2024. PMID: 39287435 Free PMC article. No abstract available.
Abstract
Background and aims: An electrical storm (ES) is a clinical emergency with a paucity of established treatment options. Despite initial encouraging reports about the safety and effectiveness of percutaneous stellate ganglion block (PSGB), many questions remained unsettled and evidence from a prospective multicentre study was still lacking. For these purposes, the STAR study was designed.
Methods: This is a multicentre observational study enrolling patients suffering from an ES refractory to standard treatment from 1 July 2017 to 30 June 2023. The primary outcome was the reduction of treated arrhythmic events by at least 50% comparing the 12 h following PSGB with the 12 h before the procedure. STAR operators were specifically trained to both the anterior anatomical and the lateral ultrasound-guided approach.
Results: A total of 131 patients from 19 centres were enrolled and underwent 184 PSGBs. Patients were mainly male (83.2%) with a median age of 68 (63.8-69.2) years and a depressed left ventricular ejection fraction (25.0 ± 12.3%). The primary outcome was reached in 92% of patients, and the median reduction of arrhythmic episodes between 12 h before and after PSGB was 100% (interquartile range -100% to -92.3%). Arrhythmic episodes requiring treatment were significantly reduced comparing 12 h before the first PSGB with 12 h after the last procedure [six (3-15.8) vs. 0 (0-1), P < .0001] and comparing 1 h before with 1 h after each procedure [2 (0-6) vs. 0 (0-0), P < .001]. One major complication occurred (0.5%).
Conclusions: The findings of this large, prospective, multicentre study provide evidence in favour of the effectiveness and safety of PSGB for the treatment of refractory ES.
Keywords: Electrical storm; Neuromodulation; Stellate ganglion block; Ventricular tachycardia.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures






Similar articles
-
Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia.Europace. 2024 Mar 30;26(4):euae074. doi: 10.1093/europace/euae074. Europace. 2024. PMID: 38531027 Free PMC article.
-
Efficacy of early use of percutaneous stellate ganglion block for electrical storms.Eur Heart J Acute Cardiovasc Care. 2024 Dec 3;13(11):757-765. doi: 10.1093/ehjacc/zuae109. Eur Heart J Acute Cardiovasc Care. 2024. PMID: 39317656
-
Efficacy of percutaneous stellate ganglion block according to ventricular arrhythmia cycle length: A post hoc subanalysis of the STAR study.Heart Rhythm. 2024 Nov 15:S1547-5271(24)03568-9. doi: 10.1016/j.hrthm.2024.11.015. Online ahead of print. Heart Rhythm. 2024. PMID: 39551122
-
Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: a single-centre case series.Europace. 2021 Apr 6;23(4):581-586. doi: 10.1093/europace/euaa319. Europace. 2021. PMID: 33190159
-
Efficacy of Stellate Ganglion Blockade in Managing Electrical Storm: A Systematic Review.JACC Clin Electrophysiol. 2017 Sep;3(9):942-949. doi: 10.1016/j.jacep.2017.06.006. JACC Clin Electrophysiol. 2017. PMID: 29270467 Free PMC article.
Cited by
-
The role of antiarrhythmic drugs and stellate ganglion block in the acute management of electrical storm.Eur Heart J Suppl. 2025 Feb 19;27(Suppl 1):i154-i161. doi: 10.1093/eurheartjsupp/suae084. eCollection 2025 Feb. Eur Heart J Suppl. 2025. PMID: 39980769 Free PMC article.
-
Hydrocarbon Exposure in Myocarditis: Rare Toxic Cause or Trigger? Insights from a Biopsy-Proven Fulminant Viral Case and a Systematic Literature Review.Int J Mol Sci. 2025 Apr 24;26(9):4006. doi: 10.3390/ijms26094006. Int J Mol Sci. 2025. PMID: 40362246 Free PMC article.
-
Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device's patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC.Europace. 2024 Nov 1;26(11):euae272. doi: 10.1093/europace/euae272. Europace. 2024. PMID: 39478667 Free PMC article.
-
Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesia.Europace. 2024 Mar 30;26(4):euae074. doi: 10.1093/europace/euae074. Europace. 2024. PMID: 38531027 Free PMC article.
-
[Research Progress in Stellate Ganglion Block and Regulation of Autonomic Nervous Functions].Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1604-1609. doi: 10.12182/20241160510. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39990849 Free PMC article. Review. Chinese.